Begin main content

Reports

We found 6590 result(s)

Genome-Wide Sequencing: Ethical Considerations

Last Updated: November 12, 2019
Result type: Reports
Product Line: Technology Review

This Genome-Wide Sequencing: Ethical Considerations Technology Review was conducted by CADTH in collaboration with Health Quality Ontario (HQO), together with a supporting rapid review of the qualitative evidence of patient preferences. Read the full HQO Health Technology Assessment project for more information. Unexplained devel...

  • Project Number: HE0020-000

erenumab (Aimovig)

Last Updated: November 12, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: erenumab
Indications: Migraine

  • Brand Name: Aimovig
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0578-000
  • Project Status: Active
  • Submission Type: New

certolizumab pegol (Cimzia)

Last Updated: November 11, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: certolizumab pegol
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: Cimzia
  • Manufacturer: UCB Canada Inc.
  • Project Number: SR0587-000
  • Project Status: Active
  • Submission Type: New Indication

budesonide (Jorveza)

Last Updated: November 11, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: budesonide
Indications: Eosinophilic esophagitis, adults

  • Brand Name: Jorveza
  • Manufacturer: AVIR Pharma Inc.
  • Project Number: SR0634-000
  • Project Status: Received
  • Submission Type: New

tafamidis (TBC)

Last Updated: November 8, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: tafamidis
Indications: transthyretin-mediated amyloidosis

  • Brand Name: TBC
  • Manufacturer: Pfizer Canada
  • Project Number: SR0625-000
  • Project Status: Active
  • Submission Type: New